Literature DB >> 5480242

Introduction.

H Wilson.   

Abstract

Mesh：

Year:  1970        PMID： 5480242

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN： 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  7 in total

Review 1.  Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors.

Authors:  Lillian Sun; Joshua Arbesman; Melissa Piliang
Journal:  Arch Dermatol Res       Date:  2020-06-09       Impact factor: 3.017

2.  Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.

Authors:  Ahmet Murat Aydin; Dilek E Baydar; Berk Hazir; Berrin Babaoglu; Cenk Y Bilen
Journal:  World J Urol       Date:  2020-01-03       Impact factor: 4.226

3.  Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells.

Authors:  Jason B Williams; Shuyin Li; Emily F Higgs; Alexandra Cabanov; Xiaozhong Wang; Haochu Huang; Thomas F Gajewski
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

4.  Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.

Authors:  Xiaoqiang Gu; Qiqi Zhang; Xueying Wu; Yue Fan; Jianxin Qian
Journal:  World J Surg Oncol       Date:  2021-04-12       Impact factor: 2.754

5.  First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immunological activity.

Authors:  Peter Ruf; Hartwig W Bauer; Alexandra Schoberth; Claudia Kellermann; Horst Lindhofer
Journal:  Cancer Immunol Immunother       Date:  2021-04-10       Impact factor: 6.968

Review 6.  Understanding genomics and the immune environment of penile cancer to improve therapy.

Authors:  Ahmet Murat Aydin; Jad Chahoud; Jacob J Adashek; Mounsif Azizi; Anthony Magliocco; Jeffrey S Ross; Andrea Necchi; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2020-08-18       Impact factor: 14.432

7.  Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models.

Authors:  Chi-Ping Huang; Chun-Chie Wu; Chih-Rong Shyr
Journal:  Cancer Immunol Immunother       Date:  2020-11-06       Impact factor: 6.968
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.